Penobscot Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.98M | Sell |
16,503
-453
| -3% | -$155K | 0.41% | 64 |
|
|
2026
Q1 | $5.97M | Buy |
16,956
+572
| +3% | +$204K | 0.47% | 55 |
|
|
2025
Q4 | $5.36M | Sell |
16,384
-400
| -2% | -$127K | 0.4% | 58 |
|
|
2025
Q3 | $4.74M | Buy |
16,784
+79
| +0.5% | +$22.9K | 0.36% | 65 |
|
|
2025
Q2 | $4.66M | Buy |
16,705
+663
| +4% | +$188K | 0.4% | 59 |
|
|
2025
Q1 | $5M | Sell |
16,042
-216
| -1% | -$63.8K | 0.47% | 54 |
|
|
2024
Q4 | $4.24M | Sell |
16,258
-155
| -0.9% | -$46K | 0.38% | 60 |
|
|
2024
Q3 | $5.29M | Buy |
16,413
+297
| +2% | +$97.2K | 0.48% | 53 |
|
|
2024
Q2 | $5.04M | Sell |
16,116
-340
| -2% | -$99.9K | 0.49% | 49 |
|
|
2024
Q1 | $4.68M | Sell |
16,456
-2,390
| -13% | -$699K | 0.49% | 52 |
|
|
2023
Q4 | $5.43M | Sell |
18,846
-221
| -1% | -$60.2K | 0.64% | 43 |
|
|
2023
Q3 | $5.12M | Buy |
19,067
+846
| +5% | +$211K | 0.7% | 40 |
|
|
2023
Q2 | $4.05M | Sell |
18,221
-765
| -4% | -$178K | 0.66% | 44 |
|
|
2023
Q1 | $4.59M | Sell |
18,986
-38
| -0.2% | -$9.33K | 0.8% | 36 |
|
|
2022
Q4 | $5M | Sell |
19,024
-215
| -1% | -$57.6K | 0.88% | 34 |
|
|
2022
Q3 | $4.34M | Sell |
19,239
-30
| -0.2% | -$7.27K | 0.81% | 33 |
|
|
2022
Q2 | $4.69M | Buy |
19,269
+77
| +0.4% | +$18.9K | 0.81% | 37 |
|
|
2022
Q1 | $4.64M | Sell |
19,192
-1,885
| -9% | -$433K | 0.68% | 43 |
|
|
2021
Q4 | $4.74M | Sell |
21,077
-2,889
| -12% | -$610K | 0.64% | 45 |
|
|
2021
Q3 | $5.1M | Sell |
23,966
-7,324
| -23% | -$1.69M | 0.76% | 38 |
|
|
2021
Q2 | $7.63M | Sell |
31,290
-2,682
| -8% | -$660K | 1.13% | 29 |
|
|
2021
Q1 | $8.45M | Buy |
33,972
+247
| +0.7% | +$58.9K | 1.34% | 25 |
|
|
2020
Q4 | $7.75M | Buy |
33,725
+642
| +2% | +$148K | 1.3% | 26 |
|
|
2020
Q3 | $8.41M | Buy |
33,083
+299
| +0.9% | +$74.1K | 1.59% | 19 |
|
|
2020
Q2 | $7.73M | Sell |
32,784
-254
| -0.8% | -$58K | 1.59% | 19 |
|
|
2020
Q1 | $6.7M | Buy |
33,038
+1,563
| +5% | +$341K | 1.58% | 17 |
|
|
2019
Q4 | $7.59M | Buy |
31,475
+858
| +3% | +$189K | 1.42% | 18 |
|
|
2019
Q3 | $5.92M | Buy |
30,617
+465
| +2% | +$89.3K | 1.18% | 27 |
|
|
2019
Q2 | $5.56M | Buy |
30,152
+671
| +2% | +$120K | 1.14% | 28 |
|
|
2019
Q1 | $5.6M | Buy |
29,481
+845
| +3% | +$161K | 1.19% | 26 |
|
|
2018
Q4 | $5.57M | Buy |
28,636
+810
| +3% | +$158K | 1.34% | 21 |
|
|
2018
Q3 | $5.77M | Buy |
27,826
+395
| +1% | +$77.8K | 1.25% | 22 |
|
|
2018
Q2 | $5.06M | Buy |
27,431
+150
| +0.5% | +$26.5K | 1.18% | 23 |
|
|
2018
Q1 | $4.65M | Buy |
27,281
+946
| +4% | +$174K | 1.12% | 24 |
|
|
2017
Q4 | $4.58M | Buy |
26,335
+1,565
| +6% | +$277K | 1.27% | 22 |
|
|
2017
Q3 | $4.62M | Buy |
24,770
+780
| +3% | +$138K | 1.38% | 17 |
|
|
2017
Q2 | $4.13M | Buy |
23,990
+1,490
| +7% | +$242K | 1.33% | 22 |
|
|
2017
Q1 | $3.69M | Buy |
22,500
+140
| +0.6% | +$23.3K | 1.24% | 25 |
|
|
2016
Q4 | $3.27M | Buy |
22,360
+430
| +2% | +$64.7K | 1.13% | 28 |
|
|
2016
Q3 | $3.66M | Buy |
21,930
+2,215
| +11% | +$375K | 1.29% | 24 |
|
|
2016
Q2 | $3M | Buy |
19,715
+1,820
| +10% | +$283K | 1.07% | 32 |
|
|
2016
Q1 | $2.68M | Buy |
17,895
+3,160
| +21% | +$469K | 1% | 33 |
|
|
2015
Q4 | $2.39M | Buy |
14,735
+1,783
| +14% | +$280K | 0.75% | 45 |
|
|
2015
Q3 | $1.79M | Buy |
12,952
+800
| +7% | +$126K | 0.6% | 53 |
|
|
2015
Q2 | $1.87M | Buy |
12,152
+2,040
| +20% | +$327K | 0.58% | 60 |
|
|
2015
Q1 | $1.62M | Buy |
10,112
+1,505
| +17% | +$237K | 0.51% | 62 |
|
|
2014
Q4 | $1.37M | Buy |
8,607
+85
| +1% | +$13.2K | 0.43% | 74 |
|
|
2014
Q3 | $1.2M | Buy |
8,522
+1,160
| +16% | +$151K | 0.4% | 76 |
|
|
2014
Q2 | $872K | Buy |
7,362
+1,770
| +32% | +$205K | 0.29% | 85 |
|
|
2014
Q1 | $690K | Buy |
5,592
+485
| +9% | +$58.8K | 0.24% | 93 |
|
|
2013
Q4 | $582K | Buy |
5,107
+950
| +23% | +$108K | 0.21% | 100 |
|
|
2013
Q3 | $466K | Buy |
4,157
+70
| +2% | +$7.59K | 0.18% | 109 |
|
|
2013
Q2 | $404K | Buy |
+4,087
| New | +$424K | 0.17% | 114 |
|
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
Penobscot Investment Management's AMGN Position: Q2 2026 in Review
Penobscot Investment Management reduced its Amgen (AMGN) stake by 2.7% in Q2 2026, selling an estimated $155K and leaving 16,503 shares worth $5.98M. The position accounts for 0.41% of the portfolio, ranked #64.
Penobscot Investment Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.45M in Q1 2021. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Penobscot Investment Management held 16,503 shares of Amgen worth $5.98M as of Q2 2026.
- Penobscot Investment Management sold 453 Amgen shares in Q2 2026, an estimated $155K.
- Amgen made up 0.41% of Penobscot Investment Management's portfolio in Q2 2026, its #64 holding.
- Penobscot Investment Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
- Penobscot Investment Management's Amgen position peaked at $8.45M in Q1 2021.
- 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.